Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-21 Tessier-Lavigne Marc Director Grant or award · Stock option (right to buy) +8,500 48,875
2016-06-21 MARAGANORE JOHN Director Grant or award · Stock option (right to buy) +8,000 41,125
2016-06-21 Ho Maykin Director Grant or award · Stock option (right to buy) +8,000 29,250
2016-06-21 Foster-Cheek Kaye I Director Grant or award · Stock option (right to buy) +9,000 45,899
2016-06-21 Cole Douglas G. Director Grant or award · Stock option (right to buy) +8,000 31,125
2016-06-21 Clancy Paul J Director Grant or award · Stock option (right to buy) +9,000 58,400
2016-06-21 Cantley Lewis Clayton Jr. Director Grant or award · Stock option (right to buy) +8,000 176,579
2016-06-10 Biller Scott Chief Scientific Officer Exercise or conversion +15,200 $0.47 $7K 74,270
2016-06-10 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −15,200 285,991
2016-06-08 Biller Scott Chief Scientific Officer Exercise or conversion +22,306 $0.47 $10K 81,376
2016-06-08 Biller Scott Chief Scientific Officer Exercise or conversion +5,194 $31.64 $164K 86,570
2016-06-08 Biller Scott Chief Scientific Officer Sale −27,500 $65.00 $1.8M 59,070
2016-06-08 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −22,306 306,385
2016-06-08 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,194 301,191
2016-05-26 Cantley Lewis Clayton Jr. Director Sale −627 $52.88 $33K 126,548
2016-05-26 Cantley Lewis Clayton Jr. Director Sale −625 $52.88 $33K 126,568
2016-05-25 Cantley Lewis Clayton Jr. Director Sale −627 $50.50 $32K 127,175
2016-05-25 Cantley Lewis Clayton Jr. Director Sale −625 $50.50 $32K 127,193
2016-04-26 Cantley Lewis Clayton Jr. Director Sale −627 $51.88 $33K 127,802
2016-04-26 Cantley Lewis Clayton Jr. Director Sale −625 $51.88 $32K 127,818

Page 81 of 93 · 1,853 trades